Research location

Rustenburg

South Africa

Published trials7
Site observations7
Linked trials published7
Page1 / 1
Advertisement

Research activity in Rustenburg

South Africa

CureCurrent currently publishes aggregate city-level research activity for this location: 7 trials and 7 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Rustenburg

7 linked trials · page 1 of 1
Evaluating the Safety and Immunogenicity of MTBVACNCT05947890 · 2024-01-30 · 1 site observation
RECRUITING
Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)NCT05580666 · 2023-05-08 · 1 site observation
RECRUITING
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and AdultsNCT06062238 · 2024-03-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV InfectionNCT04994509 · 2021-08-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP StudyNCT04860323 · 2021-05-28 · 1 site observation
COMPLETED
A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Phosphate-Adjuvanted Clade C gp140 in Preventing Human Immunodeficiency Virus (HIV) -1 Infection in Women in Sub-Saharan AfricaNCT03060629 · 2017-11-03 · 1 site observation
TERMINATED
Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) InfectionNCT01386294 · 2011-10-01 · 1 site observation
COMPLETED

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.